跳至主要内容
临床试验/JPRN-UMIN000005586
JPRN-UMIN000005586已完成3 期

A randomized controlled trial comparing primary tumor resection plus systemic therapy with systemic therapy alone in metastatic breast cancer (JCOG1017, PRIM-BC). - A randomized controlled trial comparing primary tumor resection plus systemic therapy with systemic therapy alone in metastatic breast cancer (JCOG1017, PRIM-BC).

Japan Clinical Oncology Group (JCOG)0 个研究点目标入组 600 人开始时间: 2011年5月11日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
600

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 80years-old(—)
性别
Female

入选标准

  • 未提供

排除标准

  • First registration (no exclusion criteria at second registration) 1. Simultaneous or metachronous (within 5 years) double cancers. 2. Infectius disease to be treated. 3. Body temperature of 38C or higher. 4. Women during pregnancy or breast-feeding. 5. Psychiatric diseases. 6. Systemic and continuous steroids medication. 7. Comorbid unstable angina pectoris or history of myocardial infarction within 6 months. 8. Uncotrollable hypertension. 9. Diabetes mellitus uncontrollable or treated by continuous insulin administration .

研究者

发起方
Japan Clinical Oncology Group (JCOG)

相似试验

A randomized controlled trial comparing primary... | 临床试验